Harald F. Stock
CIK 1569188 · last filed 2016-01-07
Harald F. Stock is a corporate insider who has filed 15 SEC Form 4 insider transactions across 1 company since 2013. The most recent filing, for OVAS, was dated Jan 7, 2016. Across all open-market trades the lifetime net is +$92.6K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OVAS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
215 FIRST STREET, SUITE 240
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | 17,762 | — | — | $92.6K | 14 | 2016-01-07 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-07 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +250,000 | $0 | EDGAR |
| 2016-01-05 | Tempest Therapeutics, Inc. (OVAS) Delisted | Mixed | +1,228 | $0 | EDGAR |
| 2015-10-02 | Tempest Therapeutics, Inc. (OVAS) Delisted | Mixed | +1,413 | $0 | EDGAR |
| 2015-07-02 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +414 | $12.0K | EDGAR |
| 2015-06-08 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-02 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +345 | $12.0K | EDGAR |
| 2014-09-25 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +522 | $7.4K | EDGAR |
| 2014-08-28 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +580 | $7.5K | EDGAR |
| 2014-08-14 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +678 | $7.5K | EDGAR |
| 2014-07-31 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +830 | $7.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.